Medication info
Eprosin Tablets (Ciprofloxacin Hydrochloride Hydrate)

Eprosin Tablets (Ciprofloxacin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 199703531 · Notified 1997.03.17 · Insurance code 669902830

Summary

Main use
Treatment of bacterial infections (such as urinary tract, respiratory, and skin infections)
Who takes it
Adults
Adult dose
(Tablets) ○ Adults: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose of this medicine may be increased to 750 mg twice daily. Acute infections are generally treated for 5 ~ 10 days; continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose. 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily. 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours. 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis. 5) If only the serum creatinine is known, creatinine clearance can be calculated using the following formula: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased up to 750 mg even in patients with severe renal impairment; however, the patient's condition must be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (such as urinary tract, respiratory, and skin infections)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
View approved original text

This medication is effective against a variety of bacteria including Escherichia coli, Shigella, and Salmonella. It is used for respiratory infections excluding acute bronchitis and community-acquired pneumonia, as well as infections of the ear, nose, and throat, bacterial prostatitis, and urinary tract infections. It is also used to treat various infections such as gonococcal cervicitis and urethritis, gastrointestinal and biliary tract infections, skin and soft tissue infections, bone and joint infections, gynecological infections, and peritonitis. However, as a fluoroquinolone, it may have serious adverse reactions, and should only be used for mild infections when no other treatment options are available. This drug is effectively used in your infection treatment.

How to take

Adult dose

(Tablets) ○ Adults: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose of this medicine may be increased to 750 mg twice daily. Acute infections are generally treated for 5 ~ 10 days; continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose. 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily. 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours. 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis. 5) If only the serum creatinine is known, creatinine clearance can be calculated using the following formula: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased up to 750 mg even in patients with severe renal impairment; however, the patient's condition must be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication can cause tendonitis and tendon rupture, peripheral neuropathy, and central nervous system side effects. If severe adverse reactions are suspected, use should be stopped immediately, especially in patients with myasthenia gravis as symptoms may worsen with this medication. Additionally, this drug should be used restrictively only for certain bacterial infections and is safe only when other treatment methods are unavailable. Caution is needed for elderly patients, those with impaired kidney function, and patients taking corticosteroids, as they are at higher risk of tendon rupture. If tendon pain or inflammation occurs, rest and avoidance of physical activity is advised, and medication should be stopped immediately if symptoms appear. This medication can affect the central nervous system and may cause seizures, psychiatric symptoms, depression, and confusion, hence it should be cautiously administered to patients with epilepsy or neurological disorders. Furthermore, serious side effects such as severe membranous colitis, liver dysfunction, skin rashes, and photosensitivity may occur; if abnormal symptoms arise, consult a healthcare professional immediately. This medication has many drug interactions, particularly requiring caution when taken with antidiabetic drugs, anticoagulants, theophylline, and tizanidine. It should not be administered to pregnant or nursing women, growing children, and adolescents, and elderly patients may require dosage adjustments due to declining kidney function. In case of overdose, kidney function should be closely monitored, and necessary emergency care should be sought. Store away from direct sunlight and in a place inaccessible to children.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, decrease in hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate secretion of antidiuretic hormone, allergic reaction, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reaction, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, taste loss, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorder, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distention, dyspepsia, colitis with blood in stool, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver impairment, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, kidney impairment, elevated BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disorder, petechial rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, shock, myalgia, weakness, elevated creatine kinase, increased serum and urine myoglobin, rhabdomyolysis, cough, abnormal chest X-ray, interstitial pneumonia, visual impairment, aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.